Pricing & Access· August 8, 2026 · 14 min read
Novo Nordisk portfolio dossier (Q2 2026): Wegovy, CagriSema & obesity pipeline
By Ran Chen#Novo Nordisk#Semaglutide#Wegovy
Topic
Novo Nordisk
Novo Nordisk corporate strategy, semaglutide franchise (Ozempic, Wegovy, Rybelsus), obesity pipeline, and manufacturing build-out.